Anil Tarachandani

Anil Tarachandani is an accomplished professional in the biomedical field, currently serving as Vice President and Head of Translational Medicine at Verge Genomics, focusing on drug development and biomarkers for Amyotrophic lateral sclerosis (ALS) patients. With a robust background that includes roles such as Project Lead Director at Pfizer, where digital endpoints and biomarkers for clinical trials in cancer and rare diseases were developed, and founder of UsinLife LLC, which specialized in clinical outcomes through digital health devices, Anil has demonstrated expertise in leading interdisciplinary teams and innovative medical advancements. Additional leadership experience includes a Director role at Biogen, where novel therapies and medical devices were advanced, and various positions at Merck, Beckman Coulter, and Carnegie Mellon University. Anil holds a Ph.D. in Oncology and a solid educational foundation in Microbiology and Biotechnology.